Anti-Rejection Drug May Increase Risk Of Diabetes After Kidney Transplant, University of British Columbia Study Shows
ScienceDaily — For patients undergoing kidney transplantation, treatment with the anti-rejection drug sirolimus may lead to an increased risk of diabetes, reports a new study.